Tecentriq vs. Trodelvy

Reviewed on 4/19/2021

Are Tecentriq and Trodelvy the Same Thing?

Tecentriq (atezolizumab) and Trodelvy (sacituzumab govitecan-hziy) are monoclonal antibodies used to treat different types of cancer.

Tecentriq is used to treat patients with locally advanced or metastatic urothelial carcinoma (cancer) who have disease progression during or following platinum-containing chemotherapy, or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.

Trodelvy is used to treat adult patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease.

Side effects of Tecentriq and Trodelvy that are similar include fatigue, decreased appetite, nausea, vomiting, constipation, diarrhea, abdominal pain, anemia, and rash.

Side effects of Tecentriq that are different from Trodelvy include urinary tract infection (UTI), fever, swelling of the extremities, back or neck pain, joint pain, dehydration, itching, intestinal obstruction, urinary obstruction, blood in urine, shortness of breath, cough, acute kidney injury, venous thromboembolism, severe infection (sepsis), and pneumonia.

Side effects of Trodelvy that are different from Tecentriq include low white blood cell count (neutropenia) and hair loss.

Tecentriq may interact with other drugs.

Trodelvy may interact with UGT1A1 inhibitors or inducers.

What Are Possible Side Effects of Tecentriq?

Common side effects of Tecentriq include:

  • fatigue
  • decreased appetite
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal pain
  • urinary tract infection
  • fever
  • swelling of the extremities
  • back or neck pain
  • joint pain
  • anemia
  • dehydration
  • itching
  • rash
  • intestinal obstruction
  • urinary obstruction
  • blood in the urine (hematuria)
  • shortness of breath
  • cough
  • acute kidney injury
  • venous thromboembolism
  • severe infection (sepsis)
  • pneumonia

What Are Possible Side Effects of Trodelvy?

Side effects of Trodelvy include:

  • nausea,
  • low white blood cell count (neutropenia),
  • diarrhea,
  • fatigue,
  • anemia,
  • vomiting,
  • hair loss
  • ,
  • constipation,
  • rash,
  • decreased appetite, and
  • abdominal pain

SLIDESHOW

Skin Cancer Symptoms, Types, Images See Slideshow

What Is Tecentriq?

Tecentriq (atezolizumab) Injection for intravenous infusion is a monoclonal antibody indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma (cancer) who have disease progression during or following platinum-containing chemotherapy, or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.

What Is Trodelvy?

Trodelvy (sacituzumab govitecan-hziy) is a Trop-2-directed antibody and topoisomerase inhibitor conjugate used to treat adult patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease.

What Drugs Interact With Tecentriq?

Tecentriq may interact with other drugs. Tell your doctor all medications and supplements you use.

What Drugs Interact With Trodelvy?

Trodelvy may interact with other medicines such as:

  • UGT1A1 inhibitors or inducers

Tell your doctor all medications and supplements you use.

How Should Tecentriq be Taken?

The recommended dose of Tecentriq is 1200 mg administered as an intravenous infusion over 60 minutes every 3 weeks until disease progression or unacceptable toxicity.

How Should Trodelvy be Taken?

The recommended dose of Trodelvy is 10 mg/kg once weekly on Days 1 and 8 of continuous 21-day treatment cycles until disease progression or unacceptable toxicity.

Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
Genentech. Tecentriq Production Information.

https://www.tecentriq.com/

Gilead Sciences. Trodelvy Product Information.

https://www.trodelvy.com

Health Solutions From Our Sponsors